Our Pipeline
Aura is developing a pipeline of virus-like drug conjugate, or VDC, therapeutic candidates for high unmet need cancers that either have no approved drugs available or are poorly managed with currently available treatments.
Pipeline
Learn more about Aura’s Expanded Access Policy
Meet the Team
Aura has assembled a world-class leadership team.
Choroidal Melanoma
Our lead VDC Bel-sar is about to enter late-stage clinical trials.
Ocular Oncology
Ocular cancers are a group of rare, life-threatening conditions that affect the eyes.